- Home
- RLI vs CORT Comparison
RLI vs CORT Comparison
Compare RLI & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLI
- CORT
- Stock Information
- Founded
- RLI 1965
- CORT 1998
- Country
- RLI United States
- CORT United States
- Employees
- RLI N/A
- CORT N/A
- Industry
- RLI Property-Casualty Insurers
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- RLI Finance
- CORT Health Care
- Exchange
- RLI Nasdaq
- CORT Nasdaq
- Market Cap
- RLI 6.8B
- CORT 7.1B
- IPO Year
- RLI 1985
- CORT N/A
- Fundamental
- Price
- RLI $74.86
- CORT $78.69
- Analyst Decision
- RLI Hold
- CORT Strong Buy
- Analyst Count
- RLI 8
- CORT 4
- Target Price
- RLI $78.60
- CORT $142.00
- AVG Volume (30 Days)
- RLI 333.8K
- CORT 1.1M
- Earning Date
- RLI 07-21-2025
- CORT 05-05-2025
- Dividend Yield
- RLI 6.53%
- CORT N/A
- EPS Growth
- RLI N/A
- CORT 8.36
- EPS
- RLI 3.03
- CORT 1.14
- Revenue
- RLI $1,733,218,000.00
- CORT $685,446,000.00
- Revenue This Year
- RLI N/A
- CORT $35.85
- Revenue Next Year
- RLI $5.96
- CORT $35.22
- P/E Ratio
- RLI $24.70
- CORT $68.97
- Revenue Growth
- RLI 8.88
- CORT 30.93
- 52 Week Low
- RLI $68.50
- CORT $27.30
- 52 Week High
- RLI $91.15
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- RLI 48.75
- CORT 62.98
- Support Level
- RLI $73.02
- CORT $74.34
- Resistance Level
- RLI $76.69
- CORT $75.50
- Average True Range (ATR)
- RLI 1.19
- CORT 3.21
- MACD
- RLI 0.10
- CORT 0.50
- Stochastic Oscillator
- RLI 52.21
- CORT 92.19
About RLI RLI Corp. (DE)
RLI Corp underwrites property and casualty insurance through its subsidiaries. The company offers insurance coverage in the specialty admitted market, where the products are designed for special risks. It also offers products in the excess and surplus markets, which provides an alternative for customers with risks or loss exposures that generally cannot be written in the standard admitted market. RLI distributes property and casualty insurance through its wholly-owned branch offices that market to wholesale and retail producers. The company's insurance operation segments include Casualty, Property, and Surety and it derives a majority of its revenue from the Casualty segment.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.